Pfizer (PFE) is a publicly traded Healthcare sector company. As of October 14, 2026, PFE trades at $29.37 with a market cap of $161.87B and a P/E ratio of 37.03. PFE moved +3.40% today. Year to date, PFE is +12.67%; over the trailing twelve months it is +14.72%. Its 52-week range spans $20.92 to $29.21. Analyst consensus is buy with an average price target of $29.36. Rallies surfaces PFE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for PFE, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $29.37 |
| Market Cap | $161.87B |
| P/E Ratio | 37.03 |
| EPS | $0.76 |
| Dividend Yield | 0.43% |
| 52-Week High | $29.21 |
| 52-Week Low | $20.92 |
| Volume | 19.83M |
| Avg Volume | 0 |
| Revenue (TTM) | $63.70B |
| Net Income | $4.37B |
| Gross Margin | 73.18% |
23 analysts cover PFE: 0 strong buy, 8 buy, 14 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $29.36.